Matt Abernethy
Chief Financial Officer · NEUROCRINE BIOSCIENCES INC
- 2026
- Sep 15, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Matt Abernethy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kevin Charles Gorman - $37.82M in NBIX purchases and sales in the last 12 months
- Julie Cooke - $5.77M in NBIX purchases and sales in the last 12 months
- Kyle Gano - $4.87M in NBIX purchases and sales in the last 12 months
- Stephen A. Sherwin - $4.13M in NBIX purchases and sales in the last 12 months
- Ingrid Delaet - $3.75M in NBIX purchases and sales in the last 12 months
- Darin Lippoldt - $3.50M in NBIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Matt Abernethy?
Matt Abernethy is a corporate insider, tracked as Chief Financial Officer of NEUROCRINE BIOSCIENCES INC (NBIX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Matt Abernethy submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matt Abernethy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($363K) across all tracked filings.
